Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Fortress Biotech, Inc. (FBIO) had Normalized Pre-Tax Income of $-26.07M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$15.12M |
|
$-9.78M |
|
$2.24M |
|
$12.88M |
|
$39.05M |
|
$-23.93M |
|
$-2.14M |
|
$-26.07M |
|
|
Normalized Pre-Tax Income |
$-26.07M |
$-26.31M |
|
$-26.31M |
|
$-26.31M |
|
$-26.31M |
|
$-23.93M |
|
$-22.02M |
|
20.78M |
|
20.78M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$90.37M |
|
$3.26M |
|
$53.85M |
|
$144.22M |
|
$71.40M |
|
$57.96M |
|
$74.47M |
|
$145.87M |
|
$-1.65M |
|
$-33.51M |
|
$-1.64M |
|
27.91M |
|
| Cash Flow Statement Financials | |
$-80.19M |
|
$-15.00M |
|
$70.64M |
|
$83.36M |
|
$58.81M |
|
$-24.55M |
|
$32.73M |
|
$-0.69M |
|
$-4.02M |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
1.03 |
|
-35.64 |
|
85.20% |
|
-158.27% |
|
-158.27% |
|
-- |
|
-172.43% |
|
-64.68% |
|
$-80.19M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.15 |
|
1.45 |
|
61.92 |
|
1597.70% |
|
78.53% |
|
-18.25% |
|
-46.72% |
|
$-0.06 |
|
$-3.86 |
|
$-3.86 |
|